ACADIA Pharmaceuticals Inc. (ACAD) — Stock Score Summary

ACADIA Pharmaceuticals Inc. (ACAD) has a MoatMap StockRank of 71/100 based on Quality (72/100), Value (46/100), and Momentum (36/100) factor scores. The current signal is BUY. ACADIA Pharmaceuticals is a biotech firm dependent on a limited product portfolio, lacking the diversified, high-ROIC compounder characteristics we require.

ACADIA Pharmaceuticals is a biopharmaceutical company focused on developing and commercializing therapies for central nervous system (CNS) disorders. Its flagship product, NUPLAZID (pimavanserin), addresses Parkinson's disease psychosis, providing a proprietary solution in a high-unmet-need area. ACADIA operates as a niche player targeting specific neurological conditions with advanced drug candidates and patent protection.

Key Financial Metrics

Price$21.72
Market Cap$3.7B
P/E (TTM)9.83
P/E (Forward)24.32
Price/Book2.98
Return on Equity37.3%
Return on Invested Capital8.1%
Debt/Equity4.07
Gross Margin61.6%
Operating Margin-1.7%
Revenue Growth9.7%
Free Cash Flow$154M

ACADIA Pharmaceuticals Inc. operates in the Biotechnology industry, part of the Healthcare sector (United States).

Frequently Asked Questions

What is ACADIA Pharmaceuticals Inc.’s (ACAD) StockRank?
MoatMap’s StockRank for ACADIA Pharmaceuticals Inc. (ACAD) is 71/100, with a Buy signal. It is a composite of Quality (72), Value (46), and Momentum (36) factor ranks across MoatMap’s 19,000+ stock universe.
Does ACADIA Pharmaceuticals Inc. have an economic moat?
ACADIA Pharmaceuticals Inc. (ACAD) has a Quality factor score of 72/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is ACADIA Pharmaceuticals Inc. a buy, hold, or sell?
MoatMap’s current signal for ACADIA Pharmaceuticals Inc. (ACAD) is Buy, based on a StockRank of 71/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is ACADIA Pharmaceuticals Inc. in?
ACADIA Pharmaceuticals Inc. (ACAD) operates in the Healthcare sector, specifically the Biotechnology industry (United States).
Browse all ranked stocksACAD deep dive reportAI ChampionsHow we score stocksSense-check another stock